European Association for the Study of Diabetes

The latest news from the EASD Annual Meeting, with physician perspective, researcher interviews and clinician insight.

Meeting News

Experimental oral diabetes drug appears safe, effective in Japanese adults

September 23, 2017
Imeglimin, part of a new class of oral agents for type 2 diabetes that target mitochondrial bioenergetics, was found to be safe and effective in…
Meeting News

Biomarker may predict preeclampsia risk in women with type 1 diabetes

September 20, 2017
Pregnancy outcomes in women with childhood-onset type 1 diabetes are commonly poor, and a new biomarker could help predict which women may develop…
Meeting News

Sodium intake may interact with genetics to increase latent autoimmune diabetes risk

September 19, 2017
Increased sodium intake is associated with risks for type 2 diabetes and latent autoimmune diabetes in adults, particularly in adult carriers of the…
Meeting News

Diabetic retinopathy may help screen for CKD progression risk

September 19, 2017
The risk for chronic kidney disease progression is relatively high in the United States, and the presence of diabetic retinopathy may be a valuable…
Meeting News

Bariatric surgery improves retinal microvasculature in obesity

September 19, 2017
Adults with obesity who underwent Roux-en-Y gastric bypass or sleeve gastrectomy exhibited improvements to the vascular structure of the retina in…
Meeting News

Twice-daily aspirin may confer CV benefit in type 2 diabetes

September 18, 2017
Patients with type 2 diabetes but without existing cardiovascular disease experienced a time-dependent increase in platelet aggregation in the 24…
Meeting News

DEVOTE: Hypoglycemia, glycemic variability increase mortality risk in type 2 diabetes

September 15, 2017
In adults with type 2 diabetes, higher day-to-day fasting glycemic variability and severe hypoglycemia are independently associated with all-cause…
Meeting News

CV death risk decreases with evolocumab in atherosclerotic disease

September 15, 2017
The risks for cardiovascular death, myocardial infarction and stroke are reduced in adults with atherosclerotic disease with or without diabetes…
Meeting News

CGM improves neonatal outcomes in type 1 diabetes

September 15, 2017
Pregnant women with type 1 diabetes using continuous glucose monitoring had a lower risk for adverse neonatal outcomes and experienced reductions in…
Meeting NewsPerspective

Exenatide, placebo comparable for major adverse CV events in type 2 diabetes

September 14, 2017
The incidence of major adverse cardiovascular events was similar among adults with type 2 diabetes with or without previous cardiovascular disease…